GLP-1 series
Module 8 · Delivery
Virtual Care Models for Obesity & Cardiometabolic Disease
Convenience is real; so are the gaps. What good telehealth GLP-1 care looks like, and the guardrails that separate it from a prescription pipeline.
10 slides · 12 minutes
Video coming soon
12-minute recorded module
What this module covers
- 01Why virtual obesity care scaled so quickly
- 02Model types: payer, employer, direct-to-consumer
- 03Benefits versus blind spots
- 04Labs, vitals and body composition at a distance
- 05Continuity with primary care and oncology
- 06Quality guardrails worth requiring
Key takeaways
Access gains are real, and so are continuity gaps.
Ask who owns labs, escalation and follow-up.
Virtual care must connect back to the survivorship record.
Continue the series
Module 1
GLP-1–Based Therapies in Cardio-Oncology
Module 2
GLP-1 Receptor Agonist Therapy: The Complete Briefing
Module 3
Obesity, Cardiometabolic Health & GLP-1 Therapies
Educational information only. It does not replace advice from your oncology or primary care team, and no treatment decision should be made from this module alone.